More S'poreans Going Abroad for IVF to Choose Baby's Gender
By Asia One,
Asia One
| 08. 22. 2011
More and more Singaporeans are heading overseas for medical procedures which allow them to choose their babies' gender.
According to The Straits Times, foreign destinations such as the United States, and increasingly Thailand, let parents choose the gender of their babies through a procedure known as preimplantation genetic diagnosis (PGD), which is banned in Singapore.
These places are also well-known for their skills in in-vitro fertilisation (IVF).
Having sons important for people of Chinese ancestry
The managing director of Marvel IVF Solutions, an IVF facility in Bangkok, said 90 per cent of Singaporeans, Chinese nationals and Hong Kongers ask for boys.
That is because males are seen as heirs and capable of taking care of their siblings, the director said.
Other facilities such as Safe Fertility and PGD Centre in Bangkok and Fertility Institutes in Los Angeles also saw the same requests by Singaporean patrons, according to The Straits Times.
Embryos screened for gender or genetic diseases or both
PGD is carried out with IVF treatment and the embryos are screened for gender or genetic diseases or both, during the...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Miguel Muñoz, Cadena SER [cites Marcy Darnovsky] | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...